CLINICAL_TRIALS
research
· 2026-04-07
Clinical Trial Update: Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma [Phase 2]
Summary
A Phase 2 clinical trial update evaluating avelumab with or without radiation therapy for advanced Merkel cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING